Acute Kidney Injury in Patients on SGLT2 Inhibitors: A Propensity-Matched Analysis

OBJECTIVE: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are new medications that improve cardiovascular and renal outcomes in patients with type 2 diabetes (T2D). However, the Food and Drug Administration has issued alerts regarding increased acute kidney injury (AKI) risk with canagliflozin an...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Care
Glavni autori: Nadkarni, Girish N., Ferrandino, Rocco, Chang, Alexander, Surapaneni, Aditya, Chauhan, Kinsuk, Poojary, Priti, Saha, Aparna, Ferket, Bart, Grams, Morgan E., Coca, Steven G.
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2017
Teme:
Epidemiology/Health Services Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652593/
https://ncbi.nlm.nih.gov/pubmed/28827404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc17-1011
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items